10 completed, 8 recruiting, 6 unknown, 3 terminated. 11 Not applicable, 8 Phase 2, 3 Phase 1, 3 Phase 3, 1 Phase 4.
Follow Ascites Hepatic: new trials by email Literature Review of Ascites Hepatic trials Research Report on Ascites Hepatic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Using Bedside Ultrasound to Understand Fluid Management in Patients With Chronic Liver Disease Ultrasound measurement, Blood draw for the laboratory assessment - Cirrhosis, Ascites Hepatic | Not yet recruiting | Royal Free Hospital NHS Foundation Trust | 100 | 2026-09-01 | 2026-09-09 | |
| "Exploring the Potential Benefits of Using Dapagliflozin in Cirrhotic Chronic Liver Disease Patients- A Randomized Controlled Trial" Dapagliflozin - Ascites Hepatic | Phase 2 / Phase 3 | Recruiting | Beni-Suef University | 52 | 2026-07-01 | 2026-07-06 |
| Early TIPS in Patients With Liver Cirrhosis and Ascites Transjugular intrahepatic portosystemic shunt (TIPS) - Liver Cirrhosis, Ascites Hepatic | Not applicable | Recruiting | University Hospital Freiburg | 134 | 2025-04-01 | 2026-05-01 |
| Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites Albumin infusion (25% albumin), Normal Saline (0.9% NaCl) - Cirrhosis, Ascites Hepatic | Phase 2 | Recruiting | Anahita Rabiee MD MHS | 20 | 2025-02-28 | 2025-03-11 |
| Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal Hypertension TIPS Stent Graft - Portal Hypertension Related to Cirrhosis, Ascites Hepatic | Not applicable | Recruiting | C. R. Bard | 166 | 2024-11-21 | 2025-12-19 |
| Underdilated-stent Technique Improves Post-TIPS Encephalopathy 6mm balloon dilation, 8mm balloon dilation - Liver Cirrhosis, Variceal Bleeding, Cirrhosis | Not applicable | Recruiting | The Second Affiliated Hospital of Chongqing Medical University | 72 | 2024-11-19 | 2026-01-20 |
| Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure Determination of presepsin levels in ascites - Ascites Hepatic, Liver Failure | Unknown | Carol Davila University of Medicine and Pharmacy | 30 | 2024-08-01 | 2024-08-21 | |
| Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome Ambrisentan, Terlipressin - Hepatorenal Syndrome, Liver Cirrhosis | Phase 2 | Active not recruiting | Noorik Biopharmaceuticals AG | 54 | 2024-04-17 | 2026-04-13 |
| A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients Withings Home Blood Pressure Device and Scale, Standard of Care - Cirrhosis, Liver, Portal Hypertension | Not applicable | Completed | University of California, San Francisco | 69 | 2023-09-22 | 2025-07-22 |
| SGLT-2 Inhibitors in the Treatment of Ascites SGLT2 inhibitor - Ascites Hepatic, Cirrhosis, Liver | Active not recruiting | University of Palermo | 40 | 2023-07-15 | 2026-05-01 | |
| Achieving Portal Access With Scorpion Post-Approval Study (APASS) Scorpion Portal Vein Access Kit, Cook Transjugular Liver Access Set, Transjugular Intrahepatic Portosystemic Shunt (TIPS) - Portal Hypertension, Liver Diseases | Not applicable | Terminated | Argon Medical Devices | 3 | 2023-07-13 | 2024-12-11 |
| A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis No intervention (observational study) - Antibiotic Toxicity, Liver Cirrhosis | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 20 | 2023-07-10 | 2026-01-08 | |
| QOL and Sarcopenia in Patients With Ascites Quality of Life surveys - Ascites Hepatic, Ascites, Malignant | Recruiting | Abramson Cancer Center at Penn Medicine | 70 | 2023-05-23 | 2026-06-15 | |
| HRS-AKI Treatment With TIPS in Patients With Cirrhosis TIPS, Standard of Care - Cirrhosis, Liver, Hepatorenal Syndrome | Not applicable | Recruiting | Jena University Hospital | 124 | 2022-11-29 | 2024-11-18 |
| Empagliflozin as a Novel Therapy in Refractory Ascites Empagliflozin 10 MG, Diuretics - Ascites Hepatic | Phase 2 / Phase 3 | Completed | Alexandria University | 42 | 2022-04-21 | 2022-11-29 |
| Achieving Portal Access With Scorpion Post-Approval Study 2 Scorpion Portal Vein Access Kit - Portal Hypertension, Liver Diseases | Completed | Argon Medical Devices | 82 | 2022-02-01 | 2025-03-04 | |
| Comparison Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis KARAHOC device, Angiocatheter - Ascites Hepatic | Not applicable | Unknown | Sang Gyune Kim | 80 | 2022-01-17 | 2022-10-13 |
| Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics PHIN-214 Subcutaneous injection - Cirrhosis, Liver, Liver Fibrosis | Phase 1 | Recruiting | PharmaIN | 74 | 2022-01-03 | 2025-09-05 |
| Empagliflozin in Diuretic Refractory Ascites Empagliflozin 10 MG - Liver Cirrhosis, Cirrhosis | Phase 1 | Completed | Stanford University | 14 | 2021-11-15 | 2023-08-02 |
| S100A8/A9 and Innate Immunity in Liver Disease Cirrhosis, Liver, Immune Suppression | Unknown | St George's, University of London | 100 | 2021-09-28 | 2023-03-31 |
Showing 20 of 33. Sign in to see all of them.
Liver Cirrhosis (17) · Fibrosis (14) · Ascites (10) · Hypertension, Portal (5) · Acute Kidney Injury (3) · Acute-On-Chronic Liver Failure (2) · Hepatorenal Syndrome (2) · Hydrothorax (2) · Liver Diseases (2) · Liver Failure (2) · Vascular Diseases (2) · Bacterial Infections (1) · Carcinoma, Hepatocellular (1) · Critical Illness (1) · Diabetes Mellitus, Type 2 (1)
Pathologic Processes (25) · Pathological Conditions, Signs and Symptoms (25) · Digestive System Diseases (20) · Liver Diseases (18) · Fibrosis (10) · Hepatic Insufficiency (5) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Kidney Diseases (4) · Male Urogenital Diseases (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Cardiovascular Diseases (3) · Liver Failure (3) · Renal Insufficiency (3)
Albumins (4) · Terlipressin (4) · Portasystemic Shunt, Transjugular Intrahepatic (3) · Standard of Care (3) · Tablets (2) · dapagliflozin (2) · empagliflozin (2) · Blood Specimen Collection (1) · Ciprofloxacin (1) · Diuretics (1) · Observation (1) · Saline Solution (1) · Sodium-Glucose Transporter 2 Inhibitors (1) · Tenofovir (1) · Ularitide (1)
Argon Medical Devices (2) · Montefiore Medical Center (2) · Abramson Cancer Center at Penn Medicine (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Alexandria University (1) · Anahita Rabiee MD MHS (1) · Beni-Suef University (1) · BioVie Inc. (1) · C. R. Bard (1) · Carol Davila University of Medicine and Pharmacy (1) · Centro Hospitalar de Lisboa Central (1) · Healthgen Biotechnology Corp. (1) · Jena University Hospital (1) · Medical University of Graz (1) · Nina Kimer (1)
United States (9) · China (3) · Austria (2) · Denmark (2) · Egypt (2) · Germany (2) · India (2) · Italy (2) · United Kingdom (2) · France (1) · Israel (1) · Netherlands (1) · Portugal (1) · Romania (1) · South Korea (1)
Samuel Sigal, MD (2) · Aparna Goel, MD (1) · Arjuna Singanayagam, MBBS; PhD (1) · Cristina Ripoll, Prof. Dr. (1) · Cynthia C Jones (1) · Danyel C Carr, MS (1) · David Nguyen, MD, MBA (1) · Giuseppe Cullaro, MD, MAS (1) · Guruprasad Aithal (1) · Hui-Chuan Sun, MD&PhD (1) · Iker Navarro, MD (1) · Juan G Abraldes (1) · Lydia Giannitrapani, MD (1) · Michael Soulen, MD (1)
PMID 14762784, PMID 18775022, PMID 20036625, PMID 22030444, PMID 22321469, PMID 22873420, PMID 24480619, PMID 25042402, PMID 25735521, PMID 26614596, PMID 28506905, PMID 28512687, PMID 30643936, PMID 30940552, PMID 30992805, PMID 32294260, PMID 33027081, PMID 33524293, PMID 34966642, PMID 35261130, PMID 35266571, PMID 35667296, PMID 35821274, PMID 37020315, PMID 37582719, PMID 37926635, PMID 38235907, PMID 39384712, PMID 40097036, PMID 41039580, PMID 41205755, PMID 42693590
2019 (2)